Research on Parkinson's disease has yielded various findings, with one study indicating that early golexanolone treatment slows the disease's progression in rats. However, other studies have explored different approaches, including blocking proteins, using vitamin A supplements, and testing compounds like mirapex, baicalin, and allantoin, with some showing promise in animal models. The effectiveness of these different strategies in addressing Parkinson's disease progression is still being investigated.